title: Docking modes of BB-3497 into the PDF active site--a comparison of the pure MM and QM/MM based docking strategies.
abstract: Peptide deformylase (PDF) has emerged as an important antibacterial drug target. Considerable effort is being directed toward developing peptidic and non-peptidic inhibitors for this metalloprotein. In this work, the known peptidic inhibitor BB-3497 and its various ionization and tautomeric states are evaluated for their inhibition efficiency against PDF using a molecular mechanics (MM) approach as well as a mixed quantum mechanics/molecular mechanics (QM/MM) approach, with an aim to understand the interactions in the binding site. The evaluated Gibbs energies of binding with the mixed QM/MM approach are shown to have the best predictive power. The experimental pose is found to have the most negative Gibbs energy of binding, and also the smallest strain energy. A quantum mechanical evaluation of the active site reveals the requirement of strong chelation by the ligand with the metal ion. The investigated ligand chelates the metal ion through the two oxygens of its reverse hydroxamate moiety, particularly the N-O(-) oxygen, forming strong covalent bonds with the metal ion, which is penta-coordinated. In the uninhibited state, the metal ion is tetrahedrally coordinated, and hence chelation with the inhibitor is associated with an increase of the metal ion coordination. Thus, the strong binding of the ligand at the binding site is accounted for.
authors.forename: Tripti
authors.initials: T
authors.lastname: Kumari
authors.forename: Upasana
authors.initials: U
authors.lastname: Issar
authors.affiliation: Computational Chemistry Group, Department of Chemistry, University of Delhi, Delhi-110007, India. rkakkar@chemistry.du.ac.in.
authors.forename: Rita
authors.initials: R
authors.lastname: Kakkar
mesh_terms: D000581:Amidohydrolases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism*; D001665:Binding Sites; D002614:Chelating Agents / Q000737:chemistry / Q000494:pharmacology; D006877:Hydroxamic Acids / Q000737:chemistry* / Q000494:pharmacology; D062105:Molecular Docking Simulation; D011485:Protein Binding / Q000187:drug effects; D011789:Quantum Theory
chemical_list: C425109:BB3497; D002614:Chelating Agents; D006877:Hydroxamic Acids; D000581:Amidohydrolases; C084507:peptide deformylase